PD-Rx Pharmaceuticals, Inc. engages in the pharmaceutical services business. The company is headquartered in Oklahoma City, Oklahoma. The company went IPO on 2001-12-17. The firm has a complete line of pharmaceutical repackaging for physician dispensing as well as Web-based software to manage point-of-care dispensing. Its software solution tailored to physicians who want to add or enhance their medication dispensing capabilities. The Company’s services cater to multiple specialties, including primary care, urgent care, pain management, occupational medicine, orthopedic medicine, bariatric care, and dental practices. Its automated production line produces approximately 2,000 bottles per hour. The firm can develop private labels for repackaged pharmaceuticals and also duplicate the current design or create new artwork. The company has point of care programs for all types of orthopedic practices, such as outpatient surgery, outpatient care and workers compensation.
The Siam Cement Public Company Limited の最大収益セグメントは SCG Chemicals (SCGC) で、最新の利益発表における収益は 208,669,000,000 です。地域別に見ると、Thailand が The Siam Cement Public Company Limited の主要市場であり、収益は 276,772,000,000 です。
PD-RX Pharmaceuticals Incは収益を上げていますか?
いいえ、最新の財務諸表によると、The Siam Cement Public Company Limitedの純損失は$0です。
PD-RX Pharmaceuticals Incに負債はありますか?
いいえ、The Siam Cement Public Company Limitedの負債は0です。
PD-RX Pharmaceuticals Incの発行済株式数は何株ですか?
The Siam Cement Public Company Limitedの総発行済株式数は0株です。